Norepinephrine appears to be a safer choice than epinephrine for patients with cardiogenic shock complicating acute MI, according to results from a randomized trial. Patients given epinephrine were ...
SAN FRANCISCO -- For sepsis-induced hypotension, a restrictive fluid strategy with earlier vasopressor use didn't impact mortality compared with liberal fluids, the CLOVERS trial showed. The ...
WARRINGTON, Pa., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing early and late-stage ...
WASHINGTON, DC—A protocol focusing on early use of the Impella ventricular support device (Abiomed) in patients with acute MI complicated by cardiogenic shock may help lower the stubbornly high ...
Which vasopressors should be given through a central line? Can certain vasopressors be given through a peripheral intravenous (IV) line? Inotropes used intravenously for the treatment of hypotension ...
Istaroxime was added to currently available inotropes and vasopressors in the study - no new safety signals were identified and physiological improvements were consistent with istaroxime responses in ...
De Backer D, Biston P, Devriendt J, et al. The investigators concluded that although no significant differences in mortality were evident between these 2 vasopressor treatments, norepinephrine should ...
WARRINGTON, Pa., June 30, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a diversified company focused on revenue generation in multiple growing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback